Gravitas Pharma Private Limited

Gravitas Pharma Private Limited - chemicals and materials in Medchal, Telangana, India. FY 2026 financials & compliance.
CIN U24110TG2021PTC153062 Incorporated 13 July 2021 ROC Hyderabad HQ Medchal, Telangana, India
Active Private Limited Company chemicals and materials Startup India MSME
Data last updated
Revenue · FY 2024
₹32.45 Cr
▲ 164% YoY
Net profit · FY 2024
₹79.14 Lakh
Net margin 2.4%
EBITDA · FY 2024
₹1.32 Cr
EBITDA margin 4.1%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹50 Lakh
Issued & subscribed
Open charges
₹1.7 Cr
Secured borrowings
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings

About Gravitas Pharma Private Limited

Data last updated:

Gravitas Pharma Private Limited is a private limited company based in Medchal, Telangana, India, recognised as a startup by DPIIT. It operates in the specialty chemicals segment of the chemicals and materials sector. It was incorporated on 13 July 2021 and has been in existence for over 5 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24110TG2021PTC153062. Its GSTIN is 36AAJCG1319E1ZW (Telangana).

The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors Sai Likhita Chekuri and Swathi Korla.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 47 Ip, Medchal, Telangana, India – 501401.

As per the financials filed for FY 2024, the company reported a revenue of ₹32.45 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹79.14 Lakh (net margin 2.4%) and EBITDA of ₹1.32 Cr (EBITDA margin 4.1%).

As per MCA filings, the company has open charges of ₹1.7 Cr on record. The company has 1 deal on record (1 funding round), with disclosed funding of ₹49 Lakh; the latest was in December 2022. Its 5 peer companies in the Chemicals industry (Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 1 larger and 4 smaller; the largest is Himson Chemical Industries Private Limited with revenue of ₹33.8 Cr.

Gravitas Pharma Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-TS-20-0017224). For more details, the company can be reached via its website gravitaspharma.in.

Company details

CIN U24110TG2021PTC153062
Registration Number 153062
Incorporation Date 13 July 2021
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
MSME Classification MSME
Udyam Registration UDYAM-TS-20-0017224

Recognitions & Rankings of Gravitas Pharma

Startup India Government of India
MSME (Udyam registered) Ministry of MSME
Udyam number
UDYAM-TS-20-0017224

Contact details

Gravitas Pharma Private Limited's registered office is in Medchal, Telangana. Its website is gravitaspharma.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    47 Ip, Medchal, Telangana, India – 501401
  • Industry
    Chemicals and Materials, Specialty Chemicals, Organic Chemicals & Compounds

To see the full contact details of Gravitas Pharma Private Limited, buy the company report.

Comprehensive company report
Gravitas Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Gravitas Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Gravitas Pharma Private Limited, buy the company report.

Financials of Gravitas Pharma Private Limited

FY 2025 filings available

Gravitas Pharma Private Limited reported revenue of ₹32.45 Cr (up 164% YoY) for FY 2024.

Revenue · FY 2024
₹32.45 Cr ▲ 164%
Net profit · FY 2024
₹79.14 Lakh margin 2.4%
EBITDA · FY 2024
₹1.32 Cr margin 4.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 164%
EBITDA CAGR growth
1 year
▲ 53%

Revenue rose 164% in the latest year. EBITDA rose 53% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.32 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹79.14 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22
Profitability
EBITDA Margin4.1%
Net Profit Margin2.4%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Gravitas Pharma Private Limited, buy the company report.

Board of directors of Gravitas Pharma Private Limited

Gravitas Pharma has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Sai Likhita ChekuriDirector13 Jul 20215 Years 3 MonthsCurrent
Swathi KorlaDirector13 Jul 20215 Years 3 MonthsCurrent

Peer comparison

Gravitas Pharma Private Limited is compared with the 5 companies closest to it by revenue in the Chemicals industry (Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Himson Chemical Industries Private Limited₹33.8 Cr (FY 2025)27.0%Mumbai, Maharashtra, India
Gravitas Pharma Private Limitedthis company₹32.45 Cr (FY 2024)₹79.14 Lakh2.4%164.0%Medchal, Telangana, India
Cheons Speciality Chemicals Private Limited₹32.18 Cr (FY 2024)59.0%Bhiwadi, Rajasthan, India
Jaydev Chemical Industries Private Limited₹32.09 Cr (FY 2025)210.0%Mumbai, Maharashtra, India
United Pestichem and Nonionics Private Limited₹32.02 Cr (FY 2025)-12.0%Mumbai, Maharashtra, India
Nav Bharati Chemicals Private Limited₹31.88 Cr (FY 2025)-5.0%Hyderabad, Telangana, India

To see the full peer comparison of Gravitas Pharma Private Limited, buy the company report.

Auditor

Gravitas Pharma Private Limited is audited by B N R ASSOCIATES for the financial year 2023.

Auditor firmFinancial yearFirm registration number
B N R ASSOCIATESFY 2023000289S

Shareholding

The shareholding of Gravitas Pharma Private Limited is on record for FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2022
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Gravitas Pharma Private Limited, buy the company report.

Charges & borrowings

Open charges
₹1.7 Cr
Satisfied charges
None
Breakdown by lending institutions
State Bank of India₹1.70 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
23 Jan 2023100695921State Bank of India₹1.7 CrOpen

Total charge records: 1 View all charges

Deals & funding

Gravitas Pharma Private Limited has 1 deal on record (1 funding round), with disclosed funding of ₹49 Lakh; the latest was in December 2022.

Total deals
1
Funding round
1
Disclosed funding
₹49 Lakh

Deals on record (1 of 1)

WhenDealAmountParties
Dec 2022Funding round₹49 LakhInvestors: 2 individuals

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Gravitas Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Gravitas Pharma Private Limited has 1 active EPFO establishment as of Apr 06, 2024.

Active EPFO establishments
1

GST

Gravitas Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
36AAJCG1319E1ZWTelanganaActive23 Jul 2021

To see the full GST registrations and return filing status of Gravitas Pharma Private Limited, buy the company report.

Recent activity

Gravitas Pharma Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Sai Likhita Chekuri was appointed as Director on 13 Jul 2021.

AGM
Gravitas Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Gravitas Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with State Bank Of India amounted to Rs. 170.00 Lakh with Charge ID 100695921 was registered on 23 Jan 2023.
Appointed
Sai Likhita Chekuri was appointed as Director.
Appointed
Swathi Korla was appointed as Director.
Incorporation
13 Jul 2021
Gravitas Pharma Private Limited was registered on 13 Jul 2021 with Roc Hyderabad & aged 5 years 4 months as per MCA records.

Frequently asked questions

Gravitas Pharma is an active private limited company based in Medchal, Telangana, India. The company works in specialty chemicals, within the chemicals and materials industry. It was incorporated on 13 July 2021 (5+ years old) and is registered under CIN U24110TG2021PTC153062.

Gravitas Pharma has 2 current directors:

The latest financial statements of Gravitas Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.

The GSTIN of Gravitas Pharma is 36AAJCG1319E1ZW, registered in Telangana.

The CIN (Corporate Identification Number) of Gravitas Pharma is U24110TG2021PTC153062. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Gravitas Pharma was incorporated on 13 July 2021, making it 5+ years old. It is registered with the Registrar of Companies, Hyderabad.

Gravitas Pharma has 1 deal on record (1 funding round), with disclosed funding of ₹49 Lakh; the latest was in December 2022.

The peers of Gravitas Pharma by revenue are Himson Chemical Industries Private Limited, Cheons Speciality Chemicals Private Limited, Jaydev Chemical Industries Private Limited, United Pestichem and Nonionics Private Limited, Nav Bharati Chemicals Private Limited, all in the Chemicals industry (Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Sai Likhita Chekuri was appointed as Director on 13 Jul 2021. Swathi Korla was appointed as Director on 13 Jul 2021.

Yes, Gravitas Pharma is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).

Yes, Gravitas Pharma is registered as an MSME under Udyam registration (number: UDYAM-TS-20-0017224).